Daily Stock List
SuperCom Ltd. (SPCBF)
Today we are reporting on SuperCom Ltd. (SPCBF), here at the QualityStocks Daily Newsletter.
SuperCom Ltd. (formerly Vuance) is a leading provider of e-ID, Security, HealthCare, Homecare, and Electronic Monitoring Solutions. The Company is a provider of traditional and digital identity solutions. They provide advanced electronic monitoring, identification and security products and solutions, to governments, and private and public organizations globally. SuperCom’s shares trade on the OTC Markets’ OTCQB. The Company has their headquarters in Herzliya, Israel.
This past March, SuperCom announced that they changed their corporate name from Vuance to SuperCom. Supercom is Vuance's former name; it still holds strong brand value as a leader in national e-ID and RFID. SuperCom has broadened their activities. The Company is now providing solutions for the national electronic-ID market, electronic monitoring for law enforcement, and homecare and healthcare markets, using their proprietary RFID and Mobile technology platform.
SuperCom features an innovative all-in-one field-proven RFID & mobile technology, and products, accompanied with advanced complementary services for healthcare, security, community public safety, electronic monitoring, livestock monitoring, and more. The Company has their RT Location, Tracking, Monitoring and Verification solutions. The empowering of these is by their PureRF™ wireless hybrids suite of products and technologies. All of these are operated by a secure, proprietary web-based, interactive, user-friendly interface.
SuperCom’s products include a broad spectrum of smart tags, receivers and monitoring software. The Company’s RFID technologies are highly energy efficient with extended battery life. In addition, they are ultra long range, as well as optimized through software for their specific purposes. The Company provides security, location and tracking services for a wide variety of vertical markets and applications.
Recently, SuperCom announced that they appointed Mr. Doron Ilan to serve as their Chief Financial Officer (CFO). Mr. Ilan brings to SuperCom a wealth of experience in corporate finance, mergers & acquisitions and public offerings. In his most recent position, he served as Chief Financial Officer of 012 Smile Telecom.
SuperCom Ltd. (SPCBF), closed Wednesday's trading session at $0.40, down 3.15%, on 380,404 volume with 18 trades. The average volume for the last 60 days is 137,291 and the stock's 52-week low/high is $0.007/$0.44.
Energy Fuels, Inc. (EFRFF)
Today we are highlighting Energy Fuels, Inc. (EFRFF), here at the QualityStocks Daily Newsletter.
Energy Fuels, Inc. is a conventional uranium mining company whose shares trade on the OTC Pink Current Information. In addition, the Company provides a major portion of the U.S.’s vanadium production. The Company supplies approximately 25 percent of the uranium produced in the U.S. They formerly went by the name Volcanic Metals Exploration, Inc. They changed their name to Energy Fuels, Inc. in May 2006. Energy Fuels has their headquarters in Toronto, Ontario, and a U.S. office in Lakewood, Colorado.
Energy Fuels is a fully integrated producer of uranium and vanadium, with the only operating uranium mill in the United States. They operate the White Mesa Mill for uranium ore processing. White Mesa is strategically located in Blanding, Utah, central to the uranium mines of the Four Corners region of the U.S. The facility has a licensed capacity of 2,000 tons per day; it can produce up to 8 million lbs. of uranium per year. White Mesa also has a co-recovery circuit to produce vanadium from Colorado Plateau ores. Moreover, it has an alternate feed circuit to process other uranium-bearing materials, including those derived from uranium conversion and other metal processing.
In addition, Energy Fuels has a number of producing mines, several mines on standby, and a varied portfolio of development projects located throughout the Western U.S.
Last week, Energy Fuels and Strathmore Minerals Corp. (STHJF) announced that the companies entered into a definitive arrangement agreement concerning a transaction previously announced on May 24, 2013. Pursuant to the Transaction, Energy Fuels will acquire, through a plan of arrangement in accordance with the Business Corporations Act (British Columbia), all of the issued and outstanding common shares of Strathmore Minerals.
Strathmore shareholders will receive 1.47 common shares of Energy Fuels for each common share of Strathmore held. This will result in the shareholders of Strathmore owning approximately 21 percent of the issued and outstanding shares of Energy Fuels upon completion of the Transaction based on Energy Fuels’ current common shares outstanding. Strathmore Minerals is a Canadian based resource company specializing in the strategic acquisition, exploration and development of mineral properties in the U.S.
Energy Fuels, Inc. (EFRFF), closed Wednesday's trading session at $0.025, even for the day, on 1,200 volume with 2 trades. The average volume for the last 60 days is 1,728 and the stock's 52-week low/high is $0.51/$0.10.
RXi Pharmaceuticals Corp. (RXII)
FeedBlitz reported recently on RXi Pharmaceuticals Corp. (RXII), Mina Mar Marketing Group, Stock Analyzer did earlier, and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
RXi Pharmaceuticals Corp. is a biotechnology company focusing on discovering, developing, and commercializing innovative therapies based on their proprietary, next-generation RNAi (RNA interference) platform. Building on the pioneering work of scientific founder and Nobel Laureate Dr. Craig Mello, the Company’s first RNAi product candidate, RXI-109, entered into RXi's first human trial in 2012. RXi Pharmaceuticals has their corporate headquarters in Westborough, Massachusetts.
RNAi is a naturally occurring phenomenon; short double-stranded RNAs interfere with the expression of targeted genes. The development of therapeutics based on RNAi technology leverages this phenomenon and potentially allows the Company to reduce the expression of particular genes within living cells.
The Company’s RXI-109 targets connective tissue growth factor (CTGF), a key regulatory of fibrosis and scar formation. RXI-109 is initially undergoing development to reduce or inhibit scar formation in the skin following surgery.
RXi Pharmaceuticals’ next generation therapeutic platform is sd-rxRNA®. A successful RNAi therapeutic platform includes stable, specific and potent RNAi compounds. A successful platform also includes the ability to deliver these compounds to the tissue(s) of choice. Scientists at RXi have used an alternative approach to delivery: drug-like properties were built into the RNAi compound itself.
These novel compounds are termed ‘self-delivering’ RNAi compounds or sd-rxRNA. RXI-109 is a proprietary sd-rxRNA® compound that has been shown in vitro and in animals to reduce mRNA for connective tissue growth factor (CTGF).
Earlier this month, RXi Pharmaceuticals announced the unblinded results of the first of their 2 placebo-controlled double blind studies in volunteers with their anti-scarring agent RXI-109. Over-expression of this protein in wounds has been associated with abnormal scarring as seen in hypertrophic scars and keloids. RXI-109 was well tolerated and produced a statistically significant and dose dependent reduction of Connective Tissue Growth Factor (CTGF).
Today, OTC Markets Group Inc. (OTCM) announced that RXi Pharmaceuticals (RXII) has upgraded to OTCQX®. RXi Pharmaceuticals began trading today on OTCQX U.S. This is a segment of the OTCQX marketplace reserved for high-quality U.S. companies that meet financial standards, undergo management reviews and provide timely news and disclosure to investors.
RXi Pharmaceuticals Corp. (RXII), closed Wednesday's trading session at $0.199, even for the day, on 1,026,028 volume with 119 trades. The average volume for the last 60 days is 843,469 and the stock's 52-week low/high is $0.0501/$0.358.
CytoSorbents Corp. (CTSO)
Alliance Advisors reported recently on CytoSorbents Corp. (CTSO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
CytoSorbents Corp. is a critical care focused company that lists on the OTC Markets’ OTCQB. The Company is using blood purification to treat life-threatening illnesses in the intensive care unit. CytoSorbents is using this blood purification to modulate the immune system and fight multiple organ failure. The foundation of their purification technology is on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbents has their headquarters in Monmouth Junction, New Jersey.
The Company's flagship product is CytoSorb®. This product has approval in the European Union (EU) as a safe and effective extracorporeal cytokine filter. It is broadly indicated for use in any clinical situation where cytokines are elevated. The design of it is to reduce the "cytokine storm" that could otherwise cause massive inflammation, organ failure and death in common critical illnesses. These illnesses include sepsis, burn injury, trauma, lung injury, and pancreatitis.
CytoSorb® is a first-in-class extracorporeal cytokine filter. It is compatible with standard hemodialysis machines and blood pumps found in most hospitals. Blood is pumped out of the body, via the CytoSorb® cartridge that contains CytoSorbents proprietary blood compatible porous polymer beads; the “purified” blood is re-circulated back to the patient. In a six hour period, a patient's entire blood volume can be treated approximately 20 times.
CytoSorbents has several products under development. These are all based upon the same underlying blood purification technology. These products include HemoDefend™, ContrastSorb, DrugSorb, as well as others.
Last week, CytoSorbents announced that they entered into an exclusive distribution agreement with Hitit Medical Systems to distribute CytoSorb® in Turkey. The initial term of the agreement is three years. It is subject to yearly minimum guaranteed orders of CytoSorb® to maintain exclusivity.
This week, CytoSorbents announced that the United States Food and Drug Administration (FDA) granted approval to commence a U.S.-based human pilot study using CytoSorb® for the treatment of rhabdomyolysis due to trauma under an Investigational Device Exemption (IDE). Rhabdomyolysis is caused by the massive release of myoglobin from severely injured skeletal muscle that can lead to kidney failure. The study was initiated by and will be funded by the U.S. Air Force. CytoSorbents is the official sponsor of the study, and expects the study to begin this year.
CytoSorbents Corp. (CTSO), closed Wednesday's trading session at $0.126, up 0.80%, on 671,200 volume with 54 trades. The average volume for the last 60 days is 115,591 and the stock's 52-week low/high is $0.0921/$0.175.
Goldrush Resources Ltd. (GOD.V)
Stockhouse reported previously on Goldrush Resources Ltd. (GOD.V), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Goldrush Resources Ltd. is a junior mineral resource exploration company with headquarters in Vancouver, British Columbia. The Company has a flagship property with a near surface, open pitable deposit (Ronguen) with strong expansion potential. Goldrush has 11 strategically located properties covering more than 1,680 sq. km. in Burkina Faso, Africa.
Goldrush Resources engages in the acquisition, exploration, and development of mineral property interests in Burkina Faso. The Company primarily explores for gold ores. Burkina Faso is now Africa's third largest state for gold exploration and the fourth largest for gold production.
Goldrush Resources has expanded the Ronguen gold deposit in Burkina Faso to a 155,000 ounce measured (4.281 million tonnes at a grade of 1.12 g/t Au), 177,000 ounce Indicated (4.206 million tonnes at a grade of 1.12 g/t Au), and 52,000 ounce Inferred (890,000 tonnes at a grade of 1.85 g/t Au) gold resource (as disclosed in Mineral Resource Technical Report, Ronguen Gold Project, Burkina Faso dated July 7, 2012).
The Company has identified on their permits a substantial number of artisanal mining sites that are ready for more advanced exploration. The Ronguen Gold deposit mineralization is outlined in an open pitable deposit open to heap leach processing. The Ronguen Gold Deposit is on the Kongoussi 1 and Tikare permits. It is eight kilometers northwest of Nord Gold's Bissa gold mine.
Concerning the Ronguen North Zone Extension Drilling Program (January 2013), 18 reverse circulation (RC) drill holes totaling 1,045 meters tested shallow oxide mineralization associated with a previously undrilled 620 meter western extension of the North Zone. The North Zone consists of mineralization that responds to induced polarization resistivity surveying, and is sub-parallel to the Main Zone of Goldrush Resources' Ronguen Gold Deposit.
In late February 2013, Goldrush Resources highlighted the announcements of SEMAFO, Inc. and Roxgold, Inc. in the immediate area of the Company’s Pompoi permit. On February 21, 2013, SEMAFO reported an initial high grade in-pit inferred resource at the Siou deposit: 999,200 ounces of gold averaging 4.62 g Au/t contained within 6.7 million tonnes, located approximately 10 kilometers northwest of Pompoi.
In January, Roxgold reported additional deep, high grade drilling results from their 55 Zone deposit; it contains an indicated resource of 354,000 ounces at a grade of 17.8 g/t Au and an inferred resource of 306,000 ounces at a grade of 7.7 g/t Au1. It is 2.5 kilometers west of the Pompoi permit.
Goldrush Resources Ltd. (GOD.V), closed Wednesday's trading session at $0.025, down 16.67%, on 174,733. The stock's 52-week low/high is $0.02/$0.09.
BIO-key International, Inc. (BKYI)
FeedBlitz, SmallCapVoice, and HotStockChat reported previously on BIO-key International, Inc. (BKYI), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
BIO-key International, Inc. is a leader in fingerprint biometric identification technologies, mobile credentialing and identity verification solutions. The Company develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. Their solutions are used in local embedded original equipment manufacturer (OEM) products and some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key International has their headquarters in Wall, New Jersey.
The Company’s biometric finger identification technology is award winning, high performance, scalable, cost-effective and easy-to-deploy. It accurately identifies and authenticates users of wireless and enterprise applications. BIO-key International’s identity solutions address the four key areas of security: Protection, Privacy, Growth, and Flexibility.
The Company’s security systems authorize only those users who can be positively identified through their fingerprint alone. Their fingerprint identification algorithm converts fingerprint images into a mathematical model. This cannot be decoded to obtain the fingerprint image. The design of their solutions is to operate over any mix of network and system infrastructures.
BIO-key’s development kits are powered by their patented Vector Segment Technology™. The Company’s VST™, WEB-key® and BSP development kits are the only fingerprint biometric solutions that provide true interoperability with all major reader manufacturers. This enables an organization to seamlessly integrate fingerprint biometrics into their applications.
At the end of May, BIO-key reported that they and SW Global are implementing BIO-key's fingerprint biometric technology as part of the Nigerian SIM (NSIM) Card Registration program for the Nigerian Communications Commission (NCC), the independent National Regulatory Authority for the telecommunications industry in Nigeria. SW Global is a leading provider of Information Technology Services throughout Africa.
Earlier this month, BIO-key reported that IBM granted validation of the Company’s finger biometric authentication solutions, for IBM® Security Access Manager (ISAM) for Web. ISAM for Web provides an access control management solution to centralize network and application security policy for e-business applications. The full and complete integration of BIO-key solutions within ISAM for Web was completed and is currently available for customer implementation.
BIO-key International, Inc. (BKYI), closed Wednesday's trading session at $0.36, down 1.37%, on 479,315 volume with 76 trades. The average volume for the last 60 days is 178,086 and the stock's 52-week low/high is $0.05/$0.365.
Capital Financial Holdings, Inc. (CPFH)
We are reporting on Capital Financial Holdings, Inc. (CPFH), here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, Capital Financial Holdings, Inc., via their subsidiary, Capital Financial Services, Inc. engages in the financial services business in the U.S. The Company acquired all the assets of Capital Financial Services on January 15, 2002. The Company previously went by the name Integrity Mutual Funds, Inc. They changed their name to Capital Financial Holdings, Inc. in May of 2009. Incorporated on September 22, 1987, as a North Dakota corporation, Capital Financial Holdings has their headquarters in Minot, North Dakota.
The Company has been engaged in the financial services business since 1987. Capital Financial offers investment advisory services, insurance products, and a range of other securities to independent investment representatives, financial planners, as well as investment advisors.
As of March 31, 2013, Capital Financial Holdings had 17 full-time employees and 2 part-time employees. These consist of officers, securities distribution, data processing, compliance, accounting, and clerical support staff. The Company obtains the majority of their revenues and net income from sales of mutual funds, insurance products, and a variety of other securities through Capital Financial Services.
Their Capital Financial Services (CFS) subsidiary is a full-service brokerage firm. CFS is registered with the Securities and Exchange Commission (SEC) as an investment adviser and broker-dealer. CFS is registered with the Financial Industry Regulatory Authority, Inc. (FINRA) as a broker-dealer. The broker-dealer and investment adviser specializes in providing investment products and services to independent investment representatives, financial planners, and investment advisers. Currently, CFS supports more than 222 investment representatives and investment advisers.
Capital Financial Holdings reported net income for the quarter ended March 31, 2013, of $5,722. This is in comparison to a net loss of $397,794 for the same quarter in 2012. Total operating revenues for the quarter were $5,462,140. This represents an increase of 31 percent from $4,160,778 for the quarter ended March 31, 2012.
Fee income for the quarter ended March 31, 2013 was $229,585. This represents a decrease of 11 percent from $259,305 for the quarter ended March 31, 2012. The Company earns investment advisory fees in connection with CFS' registered investment advisor. The Company pays the registered representatives a portion of this fee income as commission expense and retains the balance. These fees constituted 4 percent of their consolidated revenues for 2013.
Commission income includes CFS commissions. Capital Financial pays the registered representatives a percentage of this income as commission expense and retains the balance. Commission income for the quarter ended March 31, 2013 was $5,109,867. This represents an increase of 32 percent from $3,864,888 for the quarter ended March 31, 2012. Commission revenues were 94 percent of Capital Financial’s consolidated revenues for 2013.
Interest and other income for the quarter ended March 31, 2013 was $122,688. This represents an increase of 235 percent from $36,585 for the quarter ended March 31, 2012. Interest and other income were 2 percent of their consolidated revenues for the three months ended March 31, 2013.
Capital Financial Holdings, Inc. (CPFH), closed Wednesday's trading session at $0.14, even for the day, on 1,107,600 volume with 12 trades. The average volume for the last 60 days is 3,358 and the stock's 52-week low/high is $0.045/$0.20.
WordLogic Corp. (WLGC)
Vantage Wire reported earlier on WordLogic Corp. (WLGC), and we highlight the Company today, here at the QualityStocks Daily Newsletter.
Based in Vancouver, British Columbia, WordLogic Corp. develops, markets, licenses and sells advanced predictive platform software designed to speed up information discovery and text input. They offer patented predictive intelligence for desktops, mobile and tablets. Their intellectual property (IP) portfolio includes six issued U.S. and European patents and three pending U.S. patent applications.
WordLogic's innovations operate on a wide array of devices. These include smartphones, PCs, cell phones, Smart TV, media players, automotive navigational systems, and infotainment and game consoles. WordLogic’s technology saves users considerable time and effort through giving them the ability to enter text rapidly via their highly developed multiple word learning prediction engine. Their software is adaptive; it has the ability to learn text that is frequently used. This includes words, phrases, names, email addresses, and phone numbers, among numerous other custom information pieces.
The Company has well-patented and unique features. These include multi-level, multi-word, and phrase or sentence fragment prediction; color-coded predictive key highlighting; information learning based on consumer and individual use, and multiple concurrent dictionaries for multi-language, industry, and custom terminology. It supports touch screens and hardware keyboards.
WordLogic’s patented WordChunking™ technology predicts letters, words and entire phrases, and continuously learns new ones. Their patented Gesturing™ technology allows workers to enter words and phrases on their devices at high speed and with full accuracy, simply with small movements of their fingers.
WordLogic for Business automatically synchronizes across all devices currently in use. It delivers a consistent, high-quality experience for the end-user, regardless of the device or platform they are using. Enterprises looking to adopt predictive text can build WordLogic for Business into their existing IT infrastructure using the Company's simple SDK. WordLogic for Business is available as either a fully hosted service from WordLogic or installed and internally hosted on the customer's systems.
The Company’s Reach™ technology was chosen as a Top 5 pick at the CTIA Las Vegas 2013. WordLogic Reach’s patent-pending technology understands the context of what one is typing and instantly gives them access to the relevant app or data source to retrieve and share information. One is then able to “reach” into these other sources and pull key information into the message they’re composing.
Last week, WordLogic announced that the U.S. Patent Office allowed patent application No. 11/036267, titled; method, system, apparatus and computer-readable media for directing input associated with a keyboard-type device. All claims within this patent application were allowed including all of the broadest claims.
WordLogic Corp. (WLGC), closed Wednesday's trading session at $0.20, even for the day, on 1,076,379 volume with 96 trades. The average volume for the last 60 days is 132,614 and the stock's 52-week low/high is $0.046/$0.2005.
The Aristocrat Group Corp. (ASCC)
The QualityStocks Daily Newsletter would like to spotlight The Aristocrat Group Corp. (ASCC). Today, The Aristocrat Group Corp. closed trading at $0.46, up 9.52%, on 420,459 volume with 113 trades. The stock’s average daily volume over the past 60 days is 331,840, and its 52-week low/high is $0.21/$1.25.
The Aristocrat Group Corp. reported today on exploration by Luxuria Brands, the company's brand management division, of potential high-profile sponsorship opportunities in professional sports to coincide with their big promotional push for the upcoming release of RWB Ultra-Premium Handcrafted Vodka. CEO of ASCC, Robert Federowicz, reminded markets how sporting events have long been a staple venue for awareness building of products in the burgeoning $21 billion U.S. spirits industry and noted that times have never been more favorable for the release of their high-end, gluten-free vodka.
The Aristocrat Group Corp. (ASCC) is a brand management company focused on providing premiere luxury goods through continual innovation. Luxuria Brands, a subsidiary of The Aristocrat Group, has been established to identify and promote unique brands that have mass market appeal across a diverse demographic.
Luxuria Brands is primarily concentrated on distilled spirits industries, with an initial focus on Vodka branding and marketing. The worldwide distilled spirits market is currently worth about $263 billion. In the U.S. alone, Vodka sales between 2004 and 2009 grew 25% from 13.9 million cases to 58.4 million cases. The clear liquor now accounts for almost a third of all distilled spirits consumed and continues to rise in popularity.
The Aristocrat Group is also pursuing opportunities in the women’s lifestyle industry. The World Bank recently estimated that the earning power of women will reach $18 trillion by 2014, which is twice the estimated 2014 GDP of China and India combined. The Aristocrat Group is working to bring fresh, innovative prenatal and postpartum solutions to women who are looking for a more comprehensive approach to wellness.
The Aristocrat Group is leveraging the marketing strengths of its team of experts to grow boutique products into powerful, recognizable brands. The company aims to take a leadership position in multiple growing markets that offer opportunities for partnership, sponsorship, and brand awareness activities. The Aristocrat Group is leveraging the marketing strengths of its team of experts to grow boutique products into powerful, recognizable brands. Disclaimer
The Aristocrat Group Corp. Company Blog
The Aristocrat Group Corp. News:
ASCC Explores Potentially Lucrative Sports Sponsoring Opportunities
ASCC Begins Brand-Building Wholesale Initiative
ASCC Ready to Hit Market with Top Shelf Vodka Everyone Can Enjoy
GNCC Capital, Inc. (GNCP)
The QualityStocks Daily Newsletter would like to spotlight GNCC Capital, Inc. (GNCP). Today, GNCC Capital, Inc. closed trading at $0.011, up 61.76%, on 4,343,030 volume with 76 trades. The stock’s average daily volume over the past 60 days is 506,170, and its 52-week low/high is $0.0048/$0.09.
GNCC Capital, Inc. (GNCP) is a gold and silver exploration company with six different projects, all of which were carefully selected due to their outstanding characteristics. The company’s geologists will supervise an extensive exploration program for these projects to prove up reserves through geological surveys and a substantial number of carefully planned drilling programs.
The company’s initial exploration properties, located in Arizona, consist of Esther Basin, Burnt Well, Clara Gold, Kit Carson, Silverfields, and Potts Mountain. GNCC Capital plans to create significant value for its initial properties portfolio through continued exploration and joint ventures, as well as through acquiring additional gold and silver exploration assets.
GNCC Capital currently holds circa 80% of its assets in gold exploration properties. The strong rise in gold prices over recent years make this company attractive to investors seeking to benefit from the increasing value of precious metals. Backed by a world-class management team with decades of experience in the financial and mining sectors, GNCC Capital is well positioned to capitalize on the upward trend.
The company’s focus is creating value for its shareholders, employees, and business and social partners through responsible and safe exploration, mining, and marketing. While gold exploration is the company’s main focus, GNCC Capital will take advantage of value-creating opportunities in other minerals where it can leverage existing assets, skills, and experience. Disclaimer
GNCC Capital, Inc. Company Blog
GNCC Capital, Inc. News:
GNCC Capital, Inc. Nears Completion of the Acquisition of the White Hills Gold Properties
GNCC Capital, Inc. Reaches Agreement to Acquire White Hills Gold Properties
GNCC Capital, Inc. Secures Additional Funding Commitment
Raptor Resources Holdings Inc. (RRHI)
The QualityStocks Daily Newsletter would like to spotlight Raptor Resources Holdings Inc. (RRHI). Today, The Aristocrat Group Corp. closed trading at $0.015, up 25.00%, on 55,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 76,024, and its 52-week low/high is $0.0002/$0.0395.
Raptor Resources Holdings Inc. (RRHI) is a publicly traded holdings company focused on mineral resource acquisition, exploration, and development. The company currently has two subsidiaries: Mabwe Minerals Inc. (MBMI), a natural resources and hard asset company engaged in the mining and commercial sales of industrial minerals & metals with first focus on barite; and TAG Minerals Inc., a mineral & metal resource acquisition, exploration, and development company with first focus on alluvial surface gold.
Mabwe Minerals has been the focus of the parent company’s efforts the last two years to move into commercial barite production. RRHI shareholders share a common interest with MBMI shareholders in the success of Dodge Mine as the parent company owns 90M shares of MBMI. The Dodge Mine property consists of three hydrothermal mountains representing 123 hectares containing multiple deposits of superior-grade barite, limestone, and talc.
TAG Minerals, along with its indigenous affiliate, TAG Minerals Zimbabwe (Private) Limited, is responsible for alluvial gold production along with the development of greenfield assets targeting bedrock gold and other potential metals & minerals. As MBMI is transitioning into commercial barite production, RRHI will now focus on building assets within TAG Minerals with the intent of moving into commercial production within the next 18 months. TAG Minerals will utilize the latest in Heavy Particle Concentrators (HPC-30/HPC-100) through its relationship with Extrac-TEC whose gold recovery and mineral separation technology captures up to 98% of alluvial gold down to 50 microns. The company is in early stage exploration evaluating potential alluvial sites to ensure they meet the company's criteria for commercial production. Coupled with MBMI's acquisition of WGB Kinsey & Company, TAG Minerals is well positioned to fast track into commercial production once the company has successfully completed its exploratory testing.
RRHI management continues to improve its balance sheet as reflected in the company's SEC 10k filing, including favorable reductions in the company's debt/liabilities and securing 54.4M shares and 14.4M warrants of RRHI from prior employees. The company is committed to growing its asset base in TAG Minerals moving forward. Disclaimer
Raptor Resources Holdings Inc. Company Blog
Raptor Resources Holdings Inc. News:
Raptor Resources Holdings Inc. Announces Engagement of QualityStocks Investor Relations Services
Mabwe Minerals Shareholder Report Card
Raptor Resources Holdings Files SEC Form 10-K, Annual Report
Rainbow Coral Corp. (RBCC)
The QualityStocks Daily Newsletter would like to spotlight Rainbow Coral Corp. (RBCC). Today, Rainbow Coral Corp. closed trading at $0.3079, up 6.14%, on 57,218 volume with 28 trades. The stock’s average daily volume over the past 60 days is 304,246, and its 52-week low/high is $0.10/$2.67.
Rainbow Coral Corp. (RBCC), via wholly owned subsidiary Rainbow Biosciences, continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. The company specifically pursues opportunities that offer short-term marketability and commercialization potential in key areas like Alzheimer's, Parkinson's, and Cancer.
Bioscience technology is a growing, dynamic field of innovation that applies life processes to practical uses, such as the manufacturing of medical devices and the development of new bioscience procedures. From pharmaceuticals to pacemakers, genetically engineered plants to gene therapy, bioscience technology can be found virtually anywhere.
The pending joint venture with Amarantus BioScience to develop and market new therapies and treatments for neurological diseases and physical traumas is a great example of the initiatives underway. In recent news, Amarantus licensed a highly promising diagnostic blood test that could become an invaluable new tool in Alzheimer's clinical trials where patient recruitment errors occur often due to inaccurate diagnosis.
The global biotech industry, currently valued at more than $84.6B, allows new players with bright ideas to quickly grab market share and create completely new markets. The exciting initiatives being driven forward by Rainbow Coral promise to transition today's leading-edge research into practical, affordable treatments for people who need them most. Disclaimer
Rainbow Coral Corp. Company Blog
Rainbow Coral Corp. News:
RBCC Explores New Funding for Expansion
RBCC Poised To Gain Share Of $142 Billion Market
RBCC to Drive Growth Through Personalized Medicine
Today before the opening bell, the Aristocrat Group announced that it is exploring high-profile sponsorship opportunities in professional sports as part of its big promotional push planned for the upcoming release of RWB Ultra-Premium Handcrafted Vodka.
“Sporting events have long been a preferred and effective way for distilled spirits brands to build awareness, because association with particular sports and athletes can help cement a brand’s identity, too,” said ASCC CEO Robert Federowicz.
Targeting the $21 billion U.S. spirits industry, in which many top brands grow their consumer loyalty with sports sponsorships, ASCC has methodically planned for the upcoming product launch. It has never been a better time to introduce a new, high-end, gluten-free vodka in the U.S.
Super premium spirits rose in volume by 8.9 percent last year, according to the Distilled Spirits Council (DISCUS). Strikingly, the super-premium vodka segment has risen 32 percent in the last two years to $1.2 billion. RWB Ultra-Premium Handcrafted Vodka is one of two distinct vodka brands that Luxuria Brands, ASCC’s brand management subsidiary, has lined up for release this year.
For more information, visit www.aristocratgroupcorp.com
GNCC Capital holds a number of gold and silver properties in Arizona, including the Clara Gold Exploration Properties in the Santa Maria Mining District in west central Arizona. The project consists of 24 lode mining claims, covering 480 acres, on land administered by the Bureau of Land Management.
There are dozens of mine shafts, adits, open pits, and other mine workings at the Clara Gold Project. The area was historically developed by the Clara Consolidated Gold & Copper Mining Co. in the early 1900’s, and is comprised of two groups of mining claims, called the Clara Mine in the northeast portion of the property, and the Moreau Mine in the southwest portion of the property.
Exploration materials for the area are available dating back to 1982, when the property was originally acquired by American Gold Minerals Corp., which assigned their interest to Goldsil Mining & Milling, with other owners following.
Underground sampling by Nevada Pacific, a previous owner, averaged .091 ounces per ton gold, and included a section of continuous chip/channel samples that averaged 0.162 ounces per ton gold over 85 feet. Nevada Pacific’s initial drilling included intervals of 45 feet at 0.097 ounces per ton gold and 15 feet at 0.089 ounces per ton gold. GNCC intends to conduct initial sampling to validate Nevada Pacific’s reported results, following which they will attempt to develop drill targets at the property.
The regional geological setting is a major east / west detachment fault. Mineralization is found in quartz veins and breccia zones hosted by the upper plate and lower plates. Detachment fault deposits were first recognized as a separate form of gold deposit in the 1980’s. The best example of an Arizona detachment gold deposit is probably the Copperstone Gold deposit, which like Clara is in the highly extended Western Arizona terrane, as well as in the “Walker Lane” gold trend. Cyprus Gold mined the approximately 500,000 ounce Copperstone open pit gold resource during the 1980’s.
For more information, visit www.GNCC-Capital.com
Mabwe Minerals, and its Dodge Mine project in Zimbabwe in southern Africa, has been chosen as a fast-track focus by Raptor Resources. Mabwe, a subsidiary of Raptor Resources, is aggressively developing a major barite (BaSO4) source in the mountainous region of northeast Zimbabwe. It’s been labeled a world-class barite (barite) deposit, due to the established volume and quality of the mineral. Dodge Mine operations are being managed by WGB Kinsey & Company, a minority-owned partner of Mabwe and Raptor and long-established mining and construction company in the country.
Barite’s primary application is in the oil and gas industry, where it is used as a weighting agent for drilling fluids to reduce pressure buildup and prevent blowouts or collapse, and that’s where the Dodge Mine production is targeted. However, barite has a number of other applications. It is used in paints, plastics, and ceramics, and helps create a durable coating for automobiles. Barite is also used in the medical industry to help enhance contrast during certain scanning procedures.
Dodge Mine is a hydrothermal mountain range, implying high quality deposits of minerals and metals. In addition to barite, the Dodge Mine site hosts limestone and talc, along with widespread gossan deposits. Gossan is essentially weathered rock, usually the exposed part of an ore deposit or mineral vein, and in this case indicates the potential presence of copper, zinc, nickel, and gold. Based on ASCON validation studies of just one part of the Dodge Mine property, 411,000 tons of barite and 531,000 tons of limestone have been confirmed, suggesting a current market value of approximately $79 million.
But the company already has a buyer lined up for the delivery of 3,000,000 metric tons of American Petroleum Institute (API) grade barite at a rate of 220,000 metric tons per year. At an average price of $150/ton, the 13.5 year agreement represents a whopping $450 million.
For more information, visit www.RaptorResourcesHoldings.com
GlobalWise Investments operates through its wholly owned subsidiary, Intellinetics, to execute Enterprise Content Management (ECM) solutions for small to mid-sized businesses. The company has established a growth pattern by leveraging an aggressive sales distribution strategy and using evolving industry trends to its advantage.
Powered by its open cloud-based computing software, GWIV aims to capture market share in the growing ECM industry by offering innovative solutions applicable to a diverse line of markets; utilizing state-of-the-art technologies to keep pace with changes in the broader industry; and using open software and its experienced management as catalysts to further drive growth.
GWIV most recently secured a new channel sales partnership with Toshiba Business Solutions AZ/CO as part of its mission to grow in the private and public sector focusing on Managed Print Services (MPS) and Managed Services.
Intellinetics’ flagship platform, Intellivue™, helps clients access and manage virtually any document that can be digitized, including files, spreadsheets, e-mails, photo, audio file, or video tape. The product is deployed based on a capacity-based monthly subscription model vs. traditional per click charge industry standard models.
Intellivue is distributed through resell partners such as hardware manufacturers, value-added resellers (VAR), and independent software vendors (ISV), and OEM and ERP partners. Some of the leading names in the industry are already utilizing the company’s technology as a reseller, including Lexmark, Kodak, Samsung, Tiburon, Global Environmental Services, Electronic Business Machines, and more.
For more information visit www.globalwiseinvestments.com or www.intellinetics.com
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Requests Orphan Drug Designation for Treatment of HPV-Associated Head and Neck Cancer with ADXS-HPV
- Consorteum Holdings, Inc. (CSRH) Enters Partnership Agreement With KO Entertainment, Inc.
- Cardium Therapeutics, Inc. (CXM) Announces Initial Voting Results And Temporary Adjournment of Annual Meeting To Be Reconvened On June 21, 2013
- DoMark International, Inc. (DOMK) Engages Leading Global Designer to Develop a New Luxury Range of Accessory Products for the Apple iPad for the $200 Billion Luxury Product Market
- GlobalWise Investments, Inc. (GWIV) Adds Toshiba Business Solutions AZ/CO as New Channel Sales Partner
- GRILLiT, Inc. (GRLT) Announces Common Stock Dividend to its Shareholders
- International Stem Cell Corp. (ISCO) Subsidiary Lifeline Skin Care Expands Asian Distribution
- Loans4Less.com, Inc. (LFLS) CEOCFO Magazine Interview Highlights Solid Market Position
- Low Carbon Technologies International, Inc. (LWCTF) Plans to Announce 6 Month YTD Financials
- Mabwe Minerals Inc. (MBMI) Announces Engagement of QualityStocks Investor Relations Services
- Rafarma Pharmaceuticals, Inc. (RAFA) Enters $50M Ceftriaxone Market and Signs Long-Term National and Regional Distribution Contracts
- Rainbow Coral Corp. (RBCC) Explores New Funding for Expansion
- Raptor Resources Holdings Inc. (RRHI) Announces Engagement of QualityStocks Investor Relations Services
- Solar Wind Energy Tower, Inc. (SWET) CEO Featured in Exclusive QualityStocks Interview
- StreamTrack, Inc. (STTK) Announces Alliance to Potentially Reach Over 300 Million Registered PPTV Users
- The Aristocrat Group Corp. (ASCC) Explores Potentially Lucrative Sports Sponsoring Opportunities
- The Guitammer Company Inc. (GTMM) ButtKicker Gamer2, Two "Butts" Are Better Than One
- VentriPoint Diagnostics Ltd. (VPTDF) Announces New Vice-President of Sales and Marketing
- VistaGen Therapeutics, Inc. (VSTA) and Duke University Publish Results on Production of Functional 3D Human Heart Tissue